Calidi Biotherapeutics (CLDI) Non Operating Income (2022 - 2026)
Calidi Biotherapeutics (CLDI) posted quarterly Non Operating Income of $405000.0 for Q4 2025, up 440.34% year-over-year from $74953.3 in Q4 2024, and up 429.27% quarter-over-quarter from -$123000.0 in Q3 2025.
Calidi Biotherapeutics (CLDI) Non Operating Income (2022 - 2026) Analysis & Trends
Calidi Biotherapeutics' Non Operating Income history runs 4 years deep, the most recent figure standing at $405000.0 for Q4 2025.
- In Q4 2025, Non Operating Income rose 440.34% year-over-year to $405000.0; the TTM figure through Dec 2025 stood at $192000.0 (up 145.82% YoY), while the FY2025 annual figure was $192000.0, up 145.82% from the prior year.
- Non Operating Income for Q4 2025 stood at $405000.0, up from -$123000.0 in the prior quarter.
- The five-year high for Non Operating Income was $5.2 million in Q3 2023, with the low at -$6.0 million in Q2 2023.
- The 4-year median for Non Operating Income is $8000.0 (2024), against an average of $289992.7.
- Peak annual rise in Non Operating Income reached 440.34% in 2025, while the deepest fall reached 815.38% in 2025.
- Calidi Biotherapeutics' Non Operating Income stood at -$3.1 million in 2022, then soared by 151.71% to $1.6 million in 2023, then sank by 107.49% to -$119000.0 in 2024, then surged by 440.34% to $405000.0 in 2025.
- Business Quant data shows CLDI's Non Operating Income at $405000.0 in Q4 2025, -$123000.0 in Q3 2025, and -$93000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 234.30 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -53.64 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | -51.63 Mn |
| 10 | Calidi Biotherapeutics | 1.88 Mn | -2.22 Mn | - | -5,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -5,000.00 |
| Dec 31, 2025 | 405,000.00 |
| Sep 30, 2025 | -123,000.00 |
| Jun 30, 2025 | -93,000.00 |
| Mar 31, 2025 | 3,000.00 |
| Dec 31, 2024 | -119,000.00 |
| Sep 30, 2024 | 156,000.00 |
| Jun 30, 2024 | 13,000.00 |
| Mar 31, 2024 | -469,000.00 |
| Dec 31, 2023 | 1.59 Mn |
| Sep 30, 2023 | 5.21 Mn |
| Jun 30, 2023 | -5.96 Mn |
| Mar 31, 2023 | -1.04 Mn |
| Dec 31, 2022 | -3.07 Mn |
| Sep 30, 2022 | 1.63 Mn |
| Jun 30, 2022 | 4.52 Mn |
| Mar 31, 2022 | 1.99 Mn |